A clinical trial to determine whether a smartwatch app that analyzes pulse-rate data can screen for a heart-rhythm disorder has enrolled more than 400,000 participants.
Nov 1, 2018
0
2
The new oral anticoagulants provide the same stroke prevention as warfarin but cause less intracranial bleeding, reports an observational study in more than 43 000 patients presented at ESC Congress 2016 today by Dr Laila ...
Aug 27, 2016
0
0
(HealthDay)—For reasons that aren't yet clear, people who battle PTSD may also be at heightened risk for the common heart rhythm disorder atrial fibrillation, researchers report.
May 9, 2018
0
25
For patients who have experienced certain common types of stroke, a small chip inserted under the skin may help physicians predict their likelihood of experiencing a second stroke, and therefore their likelihood of benefiting ...
Jun 1, 2021
0
1
In a new article published in Acta Pharmaceutica Sinica B, authors Aneesh V. Karkhanis, Gopalakrishnan Venkatesan, Ryuichi Kambayashi, Atsushi Sugiyama, Eric Chun Yong Chan and colleagues from the National University of Singapore; ...
Apr 12, 2022
0
8
(HealthDay)—For patients with congenital heart disease and atrial arrhythmias, the most common presenting arrhythmia is intra-atrial re-entrant tachycardia (IART), according to a study published in the Aug. 15 issue of ...
Aug 14, 2017
0
1
A retrospective cohort study of patients with atrial fibrillation and diabetes found that the use of non–vitamin K antagonist oral anticoagulants (NOAC) was associated with a lower risk of diabetes complications and mortality ...
Feb 15, 2022
0
49
Although smart wristbands are popular fashion gadgets for monitoring heart rate and physical activity, they are usually not sophisticated enough to provide specific and accurate information about potential health problems ...
Mar 27, 2019
0
0
Empagliflozin reduces the risk of a composite of cardiovascular death or hospitalization for heart failure in patients with heart failure and a preserved ejection fraction (HFpEF) with or without diabetes. That's the finding ...
Aug 27, 2021
0
176
The clot-inhibiting drug apixaban (trade name: Eliquis) has been approved in Germany since November 2012 for the prevention of embolism and stroke in adults with non-valvular atrial fibrillation. In an early benefit assessment ...
Aug 2, 2013
0
0
